CPRX: the cashflow

MyFinsight

For the quarter ending 2025-09-30, CPRX had $37,092K increase in cash & cash equivalents over the period. $32,438K in free cash flow.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Cash Flow	2025-09-30	2025-06-30
Net income	52,783	108,845
Depreciation	72	231
Stock-based compensation	5,670	13,447
Amortization of intangible assets	9,344	18,689
Deferred taxes	-2,417	4,755
Accretion of discount	96	138
Reduction in the carrying amount of right-of-use asset	74	146
Change in fair value of equity securities	-2,089	-308
Inventory reserve and write-offs	-292	673
Accounts receivable, net	40,546	387
Inventory, net	9,087	-218
Prepaid expenses and other current assets	6,697	387
Accounts payable	3,568	-11,065
Accrued expenses and other liabilities	13,241	5,713
Operating lease liability	-102	-197
Net cash provided by (used in) operating activities	32,438	131,341
Purchases of property and equipment	0	26
Net cash provided by (used in) investing activities	0	-26
Payment of employee withholding tax related to stock-based compensation	0	861
Proceeds from exercise of stock options	5,796	6,997
Payment of liabilities arising from asset acquisition	1,142	2,204
Proceeds from issuance of common stock	0	0
Payment of fees in connection with issuance of common stock	0	0
Net cash provided by (used in) financing activities	4,654	3,932
Net increase (decrease) in cash and cash equivalents	37,092	135,247
Cash and cash equivalents at beginning of period	517,553	-
Cash and cash equivalents at end of period	689,892	-

Unit: Thousand (K) dollars